1 Study Coverage
1.1 Compounded Bioidentical Hormone Therapy Product Introduction
1.2 Market by Type
1.2.1 Global Compounded Bioidentical Hormone Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Oestrogen
1.2.3 Progesterone
1.2.4 Testosterone
1.3 Market by Application
1.3.1 Global Compounded Bioidentical Hormone Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Compounded Bioidentical Hormone Therapy Sales Estimates and Forecasts 2017-2028
2.2 Global Compounded Bioidentical Hormone Therapy Revenue Estimates and Forecasts 2017-2028
2.3 Global Compounded Bioidentical Hormone Therapy Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Compounded Bioidentical Hormone Therapy Sales by Region
2.4.1 Global Compounded Bioidentical Hormone Therapy Sales by Region (2017-2022)
2.4.2 Global Sales Compounded Bioidentical Hormone Therapy by Region (2023-2028)
2.5 Global Compounded Bioidentical Hormone Therapy Revenue by Region
2.5.1 Global Compounded Bioidentical Hormone Therapy Revenue by Region (2017-2022)
2.5.2 Global Compounded Bioidentical Hormone Therapy Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Compounded Bioidentical Hormone Therapy Sales by Manufacturers
3.1.1 Global Top Compounded Bioidentical Hormone Therapy Manufacturers by Sales (2017-2022)
3.1.2 Global Compounded Bioidentical Hormone Therapy Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Compounded Bioidentical Hormone Therapy in 2021
3.2 Global Compounded Bioidentical Hormone Therapy Revenue by Manufacturers
3.2.1 Global Compounded Bioidentical Hormone Therapy Revenue by Manufacturers (2017-2022)
3.2.2 Global Compounded Bioidentical Hormone Therapy Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Compounded Bioidentical Hormone Therapy Revenue in 2021
3.3 Global Compounded Bioidentical Hormone Therapy Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Compounded Bioidentical Hormone Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Compounded Bioidentical Hormone Therapy Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Compounded Bioidentical Hormone Therapy Sales by Type
4.1.1 Global Compounded Bioidentical Hormone Therapy Historical Sales by Type (2017-2022)
4.1.2 Global Compounded Bioidentical Hormone Therapy Forecasted Sales by Type (2023-2028)
4.1.3 Global Compounded Bioidentical Hormone Therapy Sales Market Share by Type (2017-2028)
4.2 Global Compounded Bioidentical Hormone Therapy Revenue by Type
4.2.1 Global Compounded Bioidentical Hormone Therapy Historical Revenue by Type (2017-2022)
4.2.2 Global Compounded Bioidentical Hormone Therapy Forecasted Revenue by Type (2023-2028)
4.2.3 Global Compounded Bioidentical Hormone Therapy Revenue Market Share by Type (2017-2028)
4.3 Global Compounded Bioidentical Hormone Therapy Price by Type
4.3.1 Global Compounded Bioidentical Hormone Therapy Price by Type (2017-2022)
4.3.2 Global Compounded Bioidentical Hormone Therapy Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Compounded Bioidentical Hormone Therapy Sales by Application
5.1.1 Global Compounded Bioidentical Hormone Therapy Historical Sales by Application (2017-2022)
5.1.2 Global Compounded Bioidentical Hormone Therapy Forecasted Sales by Application (2023-2028)
5.1.3 Global Compounded Bioidentical Hormone Therapy Sales Market Share by Application (2017-2028)
5.2 Global Compounded Bioidentical Hormone Therapy Revenue by Application
5.2.1 Global Compounded Bioidentical Hormone Therapy Historical Revenue by Application (2017-2022)
5.2.2 Global Compounded Bioidentical Hormone Therapy Forecasted Revenue by Application (2023-2028)
5.2.3 Global Compounded Bioidentical Hormone Therapy Revenue Market Share by Application (2017-2028)
5.3 Global Compounded Bioidentical Hormone Therapy Price by Application
5.3.1 Global Compounded Bioidentical Hormone Therapy Price by Application (2017-2022)
5.3.2 Global Compounded Bioidentical Hormone Therapy Price Forecast by Application (2023-2028)
6 North America
6.1 North America Compounded Bioidentical Hormone Therapy Market Size by Type
6.1.1 North America Compounded Bioidentical Hormone Therapy Sales by Type (2017-2028)
6.1.2 North America Compounded Bioidentical Hormone Therapy Revenue by Type (2017-2028)
6.2 North America Compounded Bioidentical Hormone Therapy Market Size by Application
6.2.1 North America Compounded Bioidentical Hormone Therapy Sales by Application (2017-2028)
6.2.2 North America Compounded Bioidentical Hormone Therapy Revenue by Application (2017-2028)
6.3 North America Compounded Bioidentical Hormone Therapy Market Size by Country
6.3.1 North America Compounded Bioidentical Hormone Therapy Sales by Country (2017-2028)
6.3.2 North America Compounded Bioidentical Hormone Therapy Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Compounded Bioidentical Hormone Therapy Market Size by Type
7.1.1 Europe Compounded Bioidentical Hormone Therapy Sales by Type (2017-2028)
7.1.2 Europe Compounded Bioidentical Hormone Therapy Revenue by Type (2017-2028)
7.2 Europe Compounded Bioidentical Hormone Therapy Market Size by Application
7.2.1 Europe Compounded Bioidentical Hormone Therapy Sales by Application (2017-2028)
7.2.2 Europe Compounded Bioidentical Hormone Therapy Revenue by Application (2017-2028)
7.3 Europe Compounded Bioidentical Hormone Therapy Market Size by Country
7.3.1 Europe Compounded Bioidentical Hormone Therapy Sales by Country (2017-2028)
7.3.2 Europe Compounded Bioidentical Hormone Therapy Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Compounded Bioidentical Hormone Therapy Market Size by Type
8.1.1 Asia Pacific Compounded Bioidentical Hormone Therapy Sales by Type (2017-2028)
8.1.2 Asia Pacific Compounded Bioidentical Hormone Therapy Revenue by Type (2017-2028)
8.2 Asia Pacific Compounded Bioidentical Hormone Therapy Market Size by Application
8.2.1 Asia Pacific Compounded Bioidentical Hormone Therapy Sales by Application (2017-2028)
8.2.2 Asia Pacific Compounded Bioidentical Hormone Therapy Revenue by Application (2017-2028)
8.3 Asia Pacific Compounded Bioidentical Hormone Therapy Market Size by Region
8.3.1 Asia Pacific Compounded Bioidentical Hormone Therapy Sales by Region (2017-2028)
8.3.2 Asia Pacific Compounded Bioidentical Hormone Therapy Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Compounded Bioidentical Hormone Therapy Market Size by Type
9.1.1 Latin America Compounded Bioidentical Hormone Therapy Sales by Type (2017-2028)
9.1.2 Latin America Compounded Bioidentical Hormone Therapy Revenue by Type (2017-2028)
9.2 Latin America Compounded Bioidentical Hormone Therapy Market Size by Application
9.2.1 Latin America Compounded Bioidentical Hormone Therapy Sales by Application (2017-2028)
9.2.2 Latin America Compounded Bioidentical Hormone Therapy Revenue by Application (2017-2028)
9.3 Latin America Compounded Bioidentical Hormone Therapy Market Size by Country
9.3.1 Latin America Compounded Bioidentical Hormone Therapy Sales by Country (2017-2028)
9.3.2 Latin America Compounded Bioidentical Hormone Therapy Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Compounded Bioidentical Hormone Therapy Market Size by Type
10.1.1 Middle East and Africa Compounded Bioidentical Hormone Therapy Sales by Type (2017-2028)
10.1.2 Middle East and Africa Compounded Bioidentical Hormone Therapy Revenue by Type (2017-2028)
10.2 Middle East and Africa Compounded Bioidentical Hormone Therapy Market Size by Application
10.2.1 Middle East and Africa Compounded Bioidentical Hormone Therapy Sales by Application (2017-2028)
10.2.2 Middle East and Africa Compounded Bioidentical Hormone Therapy Revenue by Application (2017-2028)
10.3 Middle East and Africa Compounded Bioidentical Hormone Therapy Market Size by Country
10.3.1 Middle East and Africa Compounded Bioidentical Hormone Therapy Sales by Country (2017-2028)
10.3.2 Middle East and Africa Compounded Bioidentical Hormone Therapy Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 SottoPelle
11.1.1 SottoPelle Corporation Information
11.1.2 SottoPelle Overview
11.1.3 SottoPelle Compounded Bioidentical Hormone Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 SottoPelle Compounded Bioidentical Hormone Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 SottoPelle Recent Developments
11.2 BioTE Medical
11.2.1 BioTE Medical Corporation Information
11.2.2 BioTE Medical Overview
11.2.3 BioTE Medical Compounded Bioidentical Hormone Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 BioTE Medical Compounded Bioidentical Hormone Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 BioTE Medical Recent Developments
11.3 Advantage Pharmaceuticals
11.3.1 Advantage Pharmaceuticals Corporation Information
11.3.2 Advantage Pharmaceuticals Overview
11.3.3 Advantage Pharmaceuticals Compounded Bioidentical Hormone Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Advantage Pharmaceuticals Compounded Bioidentical Hormone Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Advantage Pharmaceuticals Recent Developments
11.4 Full Life Wellness Center
11.4.1 Full Life Wellness Center Corporation Information
11.4.2 Full Life Wellness Center Overview
11.4.3 Full Life Wellness Center Compounded Bioidentical Hormone Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Full Life Wellness Center Compounded Bioidentical Hormone Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Full Life Wellness Center Recent Developments
11.5 Neuva Aesthetics
11.5.1 Neuva Aesthetics Corporation Information
11.5.2 Neuva Aesthetics Overview
11.5.3 Neuva Aesthetics Compounded Bioidentical Hormone Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Neuva Aesthetics Compounded Bioidentical Hormone Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Neuva Aesthetics Recent Developments
11.6 Defy Medical
11.6.1 Defy Medical Corporation Information
11.6.2 Defy Medical Overview
11.6.3 Defy Medical Compounded Bioidentical Hormone Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Defy Medical Compounded Bioidentical Hormone Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Defy Medical Recent Developments
11.7 Bio station
11.7.1 Bio station Corporation Information
11.7.2 Bio station Overview
11.7.3 Bio station Compounded Bioidentical Hormone Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Bio station Compounded Bioidentical Hormone Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Bio station Recent Developments
11.8 Noven Pharmaceuticals
11.8.1 Noven Pharmaceuticals Corporation Information
11.8.2 Noven Pharmaceuticals Overview
11.8.3 Noven Pharmaceuticals Compounded Bioidentical Hormone Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Noven Pharmaceuticals Compounded Bioidentical Hormone Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Noven Pharmaceuticals Recent Developments
11.9 Novartis AG
11.9.1 Novartis AG Corporation Information
11.9.2 Novartis AG Overview
11.9.3 Novartis AG Compounded Bioidentical Hormone Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Novartis AG Compounded Bioidentical Hormone Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Novartis AG Recent Developments
11.10 Pfizer
11.10.1 Pfizer Corporation Information
11.10.2 Pfizer Overview
11.10.3 Pfizer Compounded Bioidentical Hormone Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Pfizer Compounded Bioidentical Hormone Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Pfizer Recent Developments
11.11 TherapeuticsMD
11.11.1 TherapeuticsMD Corporation Information
11.11.2 TherapeuticsMD Overview
11.11.3 TherapeuticsMD Compounded Bioidentical Hormone Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 TherapeuticsMD Compounded Bioidentical Hormone Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 TherapeuticsMD Recent Developments
11.12 Bayer AG
11.12.1 Bayer AG Corporation Information
11.12.2 Bayer AG Overview
11.12.3 Bayer AG Compounded Bioidentical Hormone Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Bayer AG Compounded Bioidentical Hormone Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Bayer AG Recent Developments
11.13 Novo Nordisk
11.13.1 Novo Nordisk Corporation Information
11.13.2 Novo Nordisk Overview
11.13.3 Novo Nordisk Compounded Bioidentical Hormone Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Novo Nordisk Compounded Bioidentical Hormone Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Novo Nordisk Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Compounded Bioidentical Hormone Therapy Industry Chain Analysis
12.2 Compounded Bioidentical Hormone Therapy Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Compounded Bioidentical Hormone Therapy Production Mode & Process
12.4 Compounded Bioidentical Hormone Therapy Sales and Marketing
12.4.1 Compounded Bioidentical Hormone Therapy Sales Channels
12.4.2 Compounded Bioidentical Hormone Therapy Distributors
12.5 Compounded Bioidentical Hormone Therapy Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Compounded Bioidentical Hormone Therapy Industry Trends
13.2 Compounded Bioidentical Hormone Therapy Market Drivers
13.3 Compounded Bioidentical Hormone Therapy Market Challenges
13.4 Compounded Bioidentical Hormone Therapy Market Restraints
14 Key Findings in The Global Compounded Bioidentical Hormone Therapy Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Table 1. Global Compounded Bioidentical Hormone Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Oestrogen
Table 3. Major Manufacturers of Progesterone
Table 4. Major Manufacturers of Testosterone
Table 5. Global Compounded Bioidentical Hormone Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Compounded Bioidentical Hormone Therapy Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Compounded Bioidentical Hormone Therapy Sales by Region (2017-2022) & (K Units)
Table 8. Global Compounded Bioidentical Hormone Therapy Sales Market Share by Region (2017-2022)
Table 9. Global Compounded Bioidentical Hormone Therapy Sales by Region (2023-2028) & (K Units)
Table 10. Global Compounded Bioidentical Hormone Therapy Sales Market Share by Region (2023-2028)
Table 11. Global Compounded Bioidentical Hormone Therapy Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Compounded Bioidentical Hormone Therapy Revenue Market Share by Region (2017-2022)
Table 13. Global Compounded Bioidentical Hormone Therapy Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Compounded Bioidentical Hormone Therapy Revenue Market Share by Region (2023-2028)
Table 15. Global Compounded Bioidentical Hormone Therapy Sales by Manufacturers (2017-2022) & (K Units)
Table 16. Global Compounded Bioidentical Hormone Therapy Sales Share by Manufacturers (2017-2022)
Table 17. Global Compounded Bioidentical Hormone Therapy Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Compounded Bioidentical Hormone Therapy Revenue Share by Manufacturers (2017-2022)
Table 19. Compounded Bioidentical Hormone Therapy Price by Manufacturers (2017-2022) &(US$/Unit)
Table 20. Global Compounded Bioidentical Hormone Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Compounded Bioidentical Hormone Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Compounded Bioidentical Hormone Therapy as of 2021)
Table 22. Compounded Bioidentical Hormone Therapy Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Compounded Bioidentical Hormone Therapy Product Offered
Table 24. Date of Manufacturers Enter into Compounded Bioidentical Hormone Therapy Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Compounded Bioidentical Hormone Therapy Sales by Type (2017-2022) & (K Units)
Table 27. Global Compounded Bioidentical Hormone Therapy Sales by Type (2023-2028) & (K Units)
Table 28. Global Compounded Bioidentical Hormone Therapy Sales Share by Type (2017-2022)
Table 29. Global Compounded Bioidentical Hormone Therapy Sales Share by Type (2023-2028)
Table 30. Global Compounded Bioidentical Hormone Therapy Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Compounded Bioidentical Hormone Therapy Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Compounded Bioidentical Hormone Therapy Revenue Share by Type (2017-2022)
Table 33. Global Compounded Bioidentical Hormone Therapy Revenue Share by Type (2023-2028)
Table 34. Compounded Bioidentical Hormone Therapy Price by Type (2017-2022) & (US$/Unit)
Table 35. Global Compounded Bioidentical Hormone Therapy Price Forecast by Type (2023-2028) & (US$/Unit)
Table 36. Global Compounded Bioidentical Hormone Therapy Sales by Application (2017-2022) & (K Units)
Table 37. Global Compounded Bioidentical Hormone Therapy Sales by Application (2023-2028) & (K Units)
Table 38. Global Compounded Bioidentical Hormone Therapy Sales Share by Application (2017-2022)
Table 39. Global Compounded Bioidentical Hormone Therapy Sales Share by Application (2023-2028)
Table 40. Global Compounded Bioidentical Hormone Therapy Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Compounded Bioidentical Hormone Therapy Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Compounded Bioidentical Hormone Therapy Revenue Share by Application (2017-2022)
Table 43. Global Compounded Bioidentical Hormone Therapy Revenue Share by Application (2023-2028)
Table 44. Compounded Bioidentical Hormone Therapy Price by Application (2017-2022) & (US$/Unit)
Table 45. Global Compounded Bioidentical Hormone Therapy Price Forecast by Application (2023-2028) & (US$/Unit)
Table 46. North America Compounded Bioidentical Hormone Therapy Sales by Type (2017-2022) & (K Units)
Table 47. North America Compounded Bioidentical Hormone Therapy Sales by Type (2023-2028) & (K Units)
Table 48. North America Compounded Bioidentical Hormone Therapy Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Compounded Bioidentical Hormone Therapy Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Compounded Bioidentical Hormone Therapy Sales by Application (2017-2022) & (K Units)
Table 51. North America Compounded Bioidentical Hormone Therapy Sales by Application (2023-2028) & (K Units)
Table 52. North America Compounded Bioidentical Hormone Therapy Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Compounded Bioidentical Hormone Therapy Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Compounded Bioidentical Hormone Therapy Sales by Country (2017-2022) & (K Units)
Table 55. North America Compounded Bioidentical Hormone Therapy Sales by Country (2023-2028) & (K Units)
Table 56. North America Compounded Bioidentical Hormone Therapy Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Compounded Bioidentical Hormone Therapy Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Compounded Bioidentical Hormone Therapy Sales by Type (2017-2022) & (K Units)
Table 59. Europe Compounded Bioidentical Hormone Therapy Sales by Type (2023-2028) & (K Units)
Table 60. Europe Compounded Bioidentical Hormone Therapy Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Compounded Bioidentical Hormone Therapy Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Compounded Bioidentical Hormone Therapy Sales by Application (2017-2022) & (K Units)
Table 63. Europe Compounded Bioidentical Hormone Therapy Sales by Application (2023-2028) & (K Units)
Table 64. Europe Compounded Bioidentical Hormone Therapy Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Compounded Bioidentical Hormone Therapy Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Compounded Bioidentical Hormone Therapy Sales by Country (2017-2022) & (K Units)
Table 67. Europe Compounded Bioidentical Hormone Therapy Sales by Country (2023-2028) & (K Units)
Table 68. Europe Compounded Bioidentical Hormone Therapy Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Compounded Bioidentical Hormone Therapy Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Compounded Bioidentical Hormone Therapy Sales by Type (2017-2022) & (K Units)
Table 71. Asia Pacific Compounded Bioidentical Hormone Therapy Sales by Type (2023-2028) & (K Units)
Table 72. Asia Pacific Compounded Bioidentical Hormone Therapy Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Compounded Bioidentical Hormone Therapy Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Compounded Bioidentical Hormone Therapy Sales by Application (2017-2022) & (K Units)
Table 75. Asia Pacific Compounded Bioidentical Hormone Therapy Sales by Application (2023-2028) & (K Units)
Table 76. Asia Pacific Compounded Bioidentical Hormone Therapy Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Compounded Bioidentical Hormone Therapy Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Compounded Bioidentical Hormone Therapy Sales by Region (2017-2022) & (K Units)
Table 79. Asia Pacific Compounded Bioidentical Hormone Therapy Sales by Region (2023-2028) & (K Units)
Table 80. Asia Pacific Compounded Bioidentical Hormone Therapy Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Compounded Bioidentical Hormone Therapy Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Compounded Bioidentical Hormone Therapy Sales by Type (2017-2022) & (K Units)
Table 83. Latin America Compounded Bioidentical Hormone Therapy Sales by Type (2023-2028) & (K Units)
Table 84. Latin America Compounded Bioidentical Hormone Therapy Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Compounded Bioidentical Hormone Therapy Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Compounded Bioidentical Hormone Therapy Sales by Application (2017-2022) & (K Units)
Table 87. Latin America Compounded Bioidentical Hormone Therapy Sales by Application (2023-2028) & (K Units)
Table 88. Latin America Compounded Bioidentical Hormone Therapy Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Compounded Bioidentical Hormone Therapy Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Compounded Bioidentical Hormone Therapy Sales by Country (2017-2022) & (K Units)
Table 91. Latin America Compounded Bioidentical Hormone Therapy Sales by Country (2023-2028) & (K Units)
Table 92. Latin America Compounded Bioidentical Hormone Therapy Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Compounded Bioidentical Hormone Therapy Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Compounded Bioidentical Hormone Therapy Sales by Type (2017-2022) & (K Units)
Table 95. Middle East and Africa Compounded Bioidentical Hormone Therapy Sales by Type (2023-2028) & (K Units)
Table 96. Middle East and Africa Compounded Bioidentical Hormone Therapy Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Compounded Bioidentical Hormone Therapy Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Compounded Bioidentical Hormone Therapy Sales by Application (2017-2022) & (K Units)
Table 99. Middle East and Africa Compounded Bioidentical Hormone Therapy Sales by Application (2023-2028) & (K Units)
Table 100. Middle East and Africa Compounded Bioidentical Hormone Therapy Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Compounded Bioidentical Hormone Therapy Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Compounded Bioidentical Hormone Therapy Sales by Country (2017-2022) & (K Units)
Table 103. Middle East and Africa Compounded Bioidentical Hormone Therapy Sales by Country (2023-2028) & (K Units)
Table 104. Middle East and Africa Compounded Bioidentical Hormone Therapy Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Compounded Bioidentical Hormone Therapy Revenue by Country (2023-2028) & (US$ Million)
Table 106. SottoPelle Corporation Information
Table 107. SottoPelle Description and Major Businesses
Table 108. SottoPelle Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 109. SottoPelle Compounded Bioidentical Hormone Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. SottoPelle Recent Developments
Table 111. BioTE Medical Corporation Information
Table 112. BioTE Medical Description and Major Businesses
Table 113. BioTE Medical Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 114. BioTE Medical Compounded Bioidentical Hormone Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. BioTE Medical Recent Developments
Table 116. Advantage Pharmaceuticals Corporation Information
Table 117. Advantage Pharmaceuticals Description and Major Businesses
Table 118. Advantage Pharmaceuticals Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 119. Advantage Pharmaceuticals Compounded Bioidentical Hormone Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Advantage Pharmaceuticals Recent Developments
Table 121. Full Life Wellness Center Corporation Information
Table 122. Full Life Wellness Center Description and Major Businesses
Table 123. Full Life Wellness Center Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 124. Full Life Wellness Center Compounded Bioidentical Hormone Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Full Life Wellness Center Recent Developments
Table 126. Neuva Aesthetics Corporation Information
Table 127. Neuva Aesthetics Description and Major Businesses
Table 128. Neuva Aesthetics Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 129. Neuva Aesthetics Compounded Bioidentical Hormone Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Neuva Aesthetics Recent Developments
Table 131. Defy Medical Corporation Information
Table 132. Defy Medical Description and Major Businesses
Table 133. Defy Medical Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 134. Defy Medical Compounded Bioidentical Hormone Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Defy Medical Recent Developments
Table 136. Bio station Corporation Information
Table 137. Bio station Description and Major Businesses
Table 138. Bio station Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 139. Bio station Compounded Bioidentical Hormone Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Bio station Recent Developments
Table 141. Noven Pharmaceuticals Corporation Information
Table 142. Noven Pharmaceuticals Description and Major Businesses
Table 143. Noven Pharmaceuticals Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 144. Noven Pharmaceuticals Compounded Bioidentical Hormone Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Noven Pharmaceuticals Recent Developments
Table 146. Novartis AG Corporation Information
Table 147. Novartis AG Description and Major Businesses
Table 148. Novartis AG Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 149. Novartis AG Compounded Bioidentical Hormone Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. Novartis AG Recent Developments
Table 151. Pfizer Corporation Information
Table 152. Pfizer Description and Major Businesses
Table 153. Pfizer Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 154. Pfizer Compounded Bioidentical Hormone Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 155. Pfizer Recent Developments
Table 156. TherapeuticsMD Corporation Information
Table 157. TherapeuticsMD Description and Major Businesses
Table 158. TherapeuticsMD Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 159. TherapeuticsMD Compounded Bioidentical Hormone Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 160. TherapeuticsMD Recent Developments
Table 161. Bayer AG Corporation Information
Table 162. Bayer AG Description and Major Businesses
Table 163. Bayer AG Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 164. Bayer AG Compounded Bioidentical Hormone Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 165. Bayer AG Recent Developments
Table 166. Novo Nordisk Corporation Information
Table 167. Novo Nordisk Description and Major Businesses
Table 168. Novo Nordisk Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 169. Novo Nordisk Compounded Bioidentical Hormone Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 170. Novo Nordisk Recent Developments
Table 171. Key Raw Materials Lists
Table 172. Raw Materials Key Suppliers Lists
Table 173. Compounded Bioidentical Hormone Therapy Distributors List
Table 174. Compounded Bioidentical Hormone Therapy Customers List
Table 175. Compounded Bioidentical Hormone Therapy Market Trends
Table 176. Compounded Bioidentical Hormone Therapy Market Drivers
Table 177. Compounded Bioidentical Hormone Therapy Market Challenges
Table 178. Compounded Bioidentical Hormone Therapy Market Restraints
Table 179. Research Programs/Design for This Report
Table 180. Key Data Information from Secondary Sources
Table 181. Key Data Information from Primary Sources
List of Figures
Figure 1. Compounded Bioidentical Hormone Therapy Product Picture
Figure 3. Global Compounded Bioidentical Hormone Therapy Market Share by Type in 2021 & 2028
Figure 3. Oestrogen Product Picture
Figure 4. Progesterone Product Picture
Figure 5. Testosterone Product Picture
Figure 6. Global Compounded Bioidentical Hormone Therapy Market Share by Application in 2021 & 2028
Figure 7. Hospital Pharmacies
Figure 8. Retail Pharmacies
Figure 9. Online Pharmacies
Figure 10. Others
Figure 11. Compounded Bioidentical Hormone Therapy Report Years Considered
Figure 12. Global Compounded Bioidentical Hormone Therapy Sales 2017-2028 (K Units)
Figure 13. Global Compounded Bioidentical Hormone Therapy Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Compounded Bioidentical Hormone Therapy Revenue 2017-2028 (US$ Million)
Figure 15. Global Compounded Bioidentical Hormone Therapy Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 16. Global Compounded Bioidentical Hormone Therapy Sales Market Share by Region (2017-2022)
Figure 17. Global Compounded Bioidentical Hormone Therapy Sales Market Share by Region (2023-2028)
Figure 18. North America Compounded Bioidentical Hormone Therapy Sales YoY (2017-2028) & (K Units)
Figure 19. North America Compounded Bioidentical Hormone Therapy Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Europe Compounded Bioidentical Hormone Therapy Sales YoY (2017-2028) & (K Units)
Figure 21. Europe Compounded Bioidentical Hormone Therapy Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Asia-Pacific Compounded Bioidentical Hormone Therapy Sales YoY (2017-2028) & (K Units)
Figure 23. Asia-Pacific Compounded Bioidentical Hormone Therapy Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Latin America Compounded Bioidentical Hormone Therapy Sales YoY (2017-2028) & (K Units)
Figure 25. Latin America Compounded Bioidentical Hormone Therapy Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Middle East & Africa Compounded Bioidentical Hormone Therapy Sales YoY (2017-2028) & (K Units)
Figure 27. Middle East & Africa Compounded Bioidentical Hormone Therapy Revenue YoY (2017-2028) & (US$ Million)
Figure 28. The Compounded Bioidentical Hormone Therapy Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 29. The Top 5 and 10 Largest Manufacturers of Compounded Bioidentical Hormone Therapy in the World: Market Share by Compounded Bioidentical Hormone Therapy Revenue in 2021
Figure 30. Global Compounded Bioidentical Hormone Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 31. Global Compounded Bioidentical Hormone Therapy Sales Market Share by Type (2017-2028)
Figure 32. Global Compounded Bioidentical Hormone Therapy Revenue Market Share by Type (2017-2028)
Figure 33. Global Compounded Bioidentical Hormone Therapy Sales Market Share by Application (2017-2028)
Figure 34. Global Compounded Bioidentical Hormone Therapy Revenue Market Share by Application (2017-2028)
Figure 35. North America Compounded Bioidentical Hormone Therapy Sales Market Share by Type (2017-2028)
Figure 36. North America Compounded Bioidentical Hormone Therapy Revenue Market Share by Type (2017-2028)
Figure 37. North America Compounded Bioidentical Hormone Therapy Sales Market Share by Application (2017-2028)
Figure 38. North America Compounded Bioidentical Hormone Therapy Revenue Market Share by Application (2017-2028)
Figure 39. North America Compounded Bioidentical Hormone Therapy Sales Share by Country (2017-2028)
Figure 40. North America Compounded Bioidentical Hormone Therapy Revenue Share by Country (2017-2028)
Figure 41. United States Compounded Bioidentical Hormone Therapy Revenue (2017-2028) & (US$ Million)
Figure 42. Canada Compounded Bioidentical Hormone Therapy Revenue (2017-2028) & (US$ Million)
Figure 43. Europe Compounded Bioidentical Hormone Therapy Sales Market Share by Type (2017-2028)
Figure 44. Europe Compounded Bioidentical Hormone Therapy Revenue Market Share by Type (2017-2028)
Figure 45. Europe Compounded Bioidentical Hormone Therapy Sales Market Share by Application (2017-2028)
Figure 46. Europe Compounded Bioidentical Hormone Therapy Revenue Market Share by Application (2017-2028)
Figure 47. Europe Compounded Bioidentical Hormone Therapy Sales Share by Country (2017-2028)
Figure 48. Europe Compounded Bioidentical Hormone Therapy Revenue Share by Country (2017-2028)
Figure 49. Germany Compounded Bioidentical Hormone Therapy Revenue (2017-2028) & (US$ Million)
Figure 50. France Compounded Bioidentical Hormone Therapy Revenue (2017-2028) & (US$ Million)
Figure 51. U.K. Compounded Bioidentical Hormone Therapy Revenue (2017-2028) & (US$ Million)
Figure 52. Italy Compounded Bioidentical Hormone Therapy Revenue (2017-2028) & (US$ Million)
Figure 53. Russia Compounded Bioidentical Hormone Therapy Revenue (2017-2028) & (US$ Million)
Figure 54. Asia Pacific Compounded Bioidentical Hormone Therapy Sales Market Share by Type (2017-2028)
Figure 55. Asia Pacific Compounded Bioidentical Hormone Therapy Revenue Market Share by Type (2017-2028)
Figure 56. Asia Pacific Compounded Bioidentical Hormone Therapy Sales Market Share by Application (2017-2028)
Figure 57. Asia Pacific Compounded Bioidentical Hormone Therapy Revenue Market Share by Application (2017-2028)
Figure 58. Asia Pacific Compounded Bioidentical Hormone Therapy Sales Share by Region (2017-2028)
Figure 59. Asia Pacific Compounded Bioidentical Hormone Therapy Revenue Share by Region (2017-2028)
Figure 60. China Compounded Bioidentical Hormone Therapy Revenue (2017-2028) & (US$ Million)
Figure 61. Japan Compounded Bioidentical Hormone Therapy Revenue (2017-2028) & (US$ Million)
Figure 62. South Korea Compounded Bioidentical Hormone Therapy Revenue (2017-2028) & (US$ Million)
Figure 63. India Compounded Bioidentical Hormone Therapy Revenue (2017-2028) & (US$ Million)
Figure 64. Australia Compounded Bioidentical Hormone Therapy Revenue (2017-2028) & (US$ Million)
Figure 65. China Taiwan Compounded Bioidentical Hormone Therapy Revenue (2017-2028) & (US$ Million)
Figure 66. Indonesia Compounded Bioidentical Hormone Therapy Revenue (2017-2028) & (US$ Million)
Figure 67. Thailand Compounded Bioidentical Hormone Therapy Revenue (2017-2028) & (US$ Million)
Figure 68. Malaysia Compounded Bioidentical Hormone Therapy Revenue (2017-2028) & (US$ Million)
Figure 69. Latin America Compounded Bioidentical Hormone Therapy Sales Market Share by Type (2017-2028)
Figure 70. Latin America Compounded Bioidentical Hormone Therapy Revenue Market Share by Type (2017-2028)
Figure 71. Latin America Compounded Bioidentical Hormone Therapy Sales Market Share by Application (2017-2028)
Figure 72. Latin America Compounded Bioidentical Hormone Therapy Revenue Market Share by Application (2017-2028)
Figure 73. Latin America Compounded Bioidentical Hormone Therapy Sales Share by Country (2017-2028)
Figure 74. Latin America Compounded Bioidentical Hormone Therapy Revenue Share by Country (2017-2028)
Figure 75. Mexico Compounded Bioidentical Hormone Therapy Revenue (2017-2028) & (US$ Million)
Figure 76. Brazil Compounded Bioidentical Hormone Therapy Revenue (2017-2028) & (US$ Million)
Figure 77. Argentina Compounded Bioidentical Hormone Therapy Revenue (2017-2028) & (US$ Million)
Figure 78. Colombia Compounded Bioidentical Hormone Therapy Revenue (2017-2028) & (US$ Million)
Figure 79. Middle East and Africa Compounded Bioidentical Hormone Therapy Sales Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Compounded Bioidentical Hormone Therapy Revenue Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Compounded Bioidentical Hormone Therapy Sales Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Compounded Bioidentical Hormone Therapy Revenue Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Compounded Bioidentical Hormone Therapy Sales Share by Country (2017-2028)
Figure 84. Middle East and Africa Compounded Bioidentical Hormone Therapy Revenue Share by Country (2017-2028)
Figure 85. Turkey Compounded Bioidentical Hormone Therapy Revenue (2017-2028) & (US$ Million)
Figure 86. Saudi Arabia Compounded Bioidentical Hormone Therapy Revenue (2017-2028) & (US$ Million)
Figure 87. UAE Compounded Bioidentical Hormone Therapy Revenue (2017-2028) & (US$ Million)
Figure 88. Compounded Bioidentical Hormone Therapy Value Chain
Figure 89. Compounded Bioidentical Hormone Therapy Production Process
Figure 90. Channels of Distribution
Figure 91. Distributors Profiles
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Figure 94. Key Executives Interviewed
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer